Skip to main content

Day: June 7, 2024

STRATA Skin Sciences’ TheraClear®X Acne Therapy System Found to be Safe and Effective for Acne Lesions Across All Fitzpatrick Skin Types with Favorable Tolerability and Patient Satisfaction as Published in Peer Reviewed Journal

Study published in the Journal of Clinical and Aesthetic Dermatology showed TheraClear®X Photopneumatic Acne therapy is a viable treatment option for patients with acne, especially for whom other acne treatments are ineffective or are poorly tolerated HORSHAM, Pa., June 07, 2024 (GLOBE NEWSWIRE) — STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announces the publication of a clinical study titled, ” A 7-Week Open-Label Trial Evaluating the Safety and Efficacy of TheraClear®X for Mitigating Mild-to-Moderate Acne in Healthy Adolescents and Young Adults,” in the June 2024 issue of the Journal of Clinical and Aesthetic Dermatology (JCAD). The...

Continue reading

BW Energy: Successful placement of new unsecured bonds

BW Energy: Successful placement of new unsecured bonds BW Energy has completed the private placement of USD 100 million of new five-year senior unsecured bonds with a coupon rate of 10% per annum. The bond placement met strong investor demand across Nordic and international markets and was significantly oversubscribed. Settlement of the bond issue is expected occur on or about 21 June 2024, subject to customary conditions precedent. An application will be made for the bonds to be listed on the Oslo Stock Exchange. Net proceeds from the new bond issue will be used for general corporate purposes. DNB Markets, part of DNB Bank ASA and Pareto Securities AS acted as Joint Bookrunners and Fearnley Securities AS and Sparebank1 Markets AS acted as Co-Managers in the transaction.For further information, please contact: Knut R. Sæthre, CFO BW...

Continue reading

Wearable Devices Announces $10 Million Standby Equity Purchase Agreement

YOKNEAM ILLIT, ISRAEL, June 07, 2024 (GLOBE NEWSWIRE) — Wearable Devices Ltd. (the “Company” or “Wearable Devices”) (Nasdaq: WLDS, WLDSW), a technology growth company specializing in artificial intelligence (“AI”)-powered touchless sensing wearables, announced that it has entered into a Standby Equity Purchase Agreement (the “SEPA”), with YA II PN, Ltd. (“YA”), a fund managed by Yorkville Advisors Global, LP. Pursuant to the terms of the SEPA, YA is committed to purchase up to $10 million (the “Commitment Amount”), of the Company’s ordinary shares at any time during the three-year period following the execution date of the SEPA. The purchase price of the ordinary shares sold to YA will be at a 3% discount of the lowest daily volume weighted average price of the Company’s ordinary shares during the three consecutive trading...

Continue reading

Notice of Annual General Meeting 28 June 2024

The Annual General Meeting of Interoil Exploration and Production ASA will be held at Schjødt AS`offices at Tordenskiolds gate 12, Oslo on the 28 June 2024 at 14:30 local (Oslo) time (CEST)Please find attached the notice for the meeting including the attendance form and proxy in English and Norwegian. The annual report for 2023 is available on the company’s web page here and on NewsWeb here.Shareholders may register their attendance digitally on VPS Investor Portal by following this link. This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act + + +Please direct any further questions to ir@interoil.no (mailto:ir@interoil.no)Interoil Exploration and Production ASA is a Norwegian based exploration and production company – listed on the Oslo Stock Exchange with focus...

Continue reading

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

DALLAS, June 07, 2024 (GLOBE NEWSWIRE) — Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on June 3, 2024, the Compensation Committee of Taysha’s Board of Directors granted three new employees, in the aggregate, options to purchase 360,000 shares of the Company’s common stock in connection with their employment. The stock options were granted under the Taysha Gene Therapies, Inc. 2023 Inducement Plan as an inducement material to the individuals entering employment with Taysha in accordance with Nasdaq Listing Rule 5635(c)(4). The stock options have an exercise price of $3.62 per share, which is equal to the closing price of Taysha’s...

Continue reading

LGI Homes Celebrates National Homeownership Month

National Homeownership MonthLGI Homes celebrates National Homeownership MonthTHE WOODLANDS, Texas, June 07, 2024 (GLOBE NEWSWIRE) — LGI Homes, Inc. (NASDAQ: LGIH) commemorates National Homeownership Month. Since 2003, LGI Homes has recognized National Homeownership Month every June by promoting the benefits of homeownership and highlighting the Company’s unique value proposition to first-time homebuyers. “At LGI Homes, we are proud to have helped over 70,000 families achieve the dream of homeownership,” said Eric Lipar, Chairman and Chief Executive Officer of LGI Homes. “Each year, we commemorate National Homeownership Month by educating buyers on the financial and personal benefits homeownership brings. Despite the current challenges to affordability, we continue to focus our efforts on making homeownership affordable...

Continue reading

Gorilla Announces $12 Million Registered Direct Offering

LONDON, June 07, 2024 (GLOBE NEWSWIRE) — Gorilla Technology Group Inc. (“Gorilla” or the “Company”) (NASDAQ: GRRR), a global solution provider in Security Intelligence, Network Intelligence, Business Intelligence, and IoT technology, today announced that it has entered into securities purchase agreements with existing institutional investors for the purchase and sale of 2,142,858 ordinary shares of the Company and warrants to purchase up to 2,142,858 ordinary shares pursuant to a registered direct offering (the “Offering”) at a combined purchase price of $5.60 per ordinary share and accompanying warrant to purchase ordinary shares. The warrants will have an exercise price of $5.90 per share, will be immediately exercisable upon issuance and will expire 5 years from issuance. The gross proceeds to Gorilla from this Offering, before...

Continue reading

Artificial Intelligence (AI) Chipsets Market to Surpass the USD 262.78 Billion Mark by 2031 | SkyQuest Technology

Westford, USA, June 07, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that Global Artificial Intelligence (AI) Chipsets Market will attain a value of USD 262.78 Billion by 2031, with a CAGR of 37.1% over the forecast period (2024-2031). AI or artificial intelligence chipsets which are cloud-based are special computer chips for artificial intelligence inference and training works. The market for artificial intelligence chipsets would see opportunities as cloud technology advanced. The need for AI chipsets based on cloud is anticipated to increase significantly in the coming years. This is due to the expanding number of data centres being established globally in a variety of industries, including IT & telecom, automotive, etc. Furthermore, cloud-based AI chipsets are provided by firms like NVIDIA Corporation, Alibaba Group Holding...

Continue reading

Hudson Technologies Announces Acquisition of USA Refrigerants

WOODCLIFF LAKE, N.J., June 07, 2024 (GLOBE NEWSWIRE) — Hudson Technologies, Inc. (NASDAQ: HDSN) today announced the acquisition of substantially all of the assets of USA United Suppliers of America, Inc. d/b/a USA Refrigerants (“USA”) for $20.7 million, subject to customary post-closing adjustments, and up to an additional $2 million in potential earnout payments. USA is a national refrigerant distributor and has been a leading purchaser of recovered refrigerants for over 25 years. Brian F. Coleman, President and Chief Executive Officer of Hudson commented, “We have known USA for many years, and they have built a highly respected reputation in our industry based on their expertise in refrigerant recovery, as well as their strong sales organization, and high level of service and commitment. With the addition of the USA team, Hudson...

Continue reading

Premier Diversified Holdings Inc. Announces Entry into Definitive Agreements in Connection with a Reverse Takeover Transaction

Not for dissemination in the United States of America VANCOUVER, British Columbia, June 07, 2024 (GLOBE NEWSWIRE) — Premier Diversified Holdings Inc. (“PDH” or the “Company”) (TSXV:PDH) is pleased to announce that, further to its press release dated September 20, 2023, whereby the Company announced entering into a non-binding letter of intent related to the acquisition, by way of reverse takeover, of AJA Health and Wellness Inc. ( “AJA Health“) and Assured Diagnosis Inc. (“ADI“) by the Company (the “RTO Transaction“), the Company has now entered into definitive agreements with respect to the RTO Transaction. The AJA Health Amalgamation Agreement On June 3, 2024, PDH, 2564858 Alberta Inc. (“Subco 1“), a wholly owned subsidiary of PDH, and AJA Health entered...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.